OUR STRATEGY

Fidia Pharma Group is an international Specialty Pharma Company based on the extensive know-how on hyaluronan, its proprietary derivatives and specialized technology platforms, which enable the Company to produce hyaluronic acids with different molecular weights and characteristics, according to the indications designed for the finished products.

The international approach is crucial to the company, whose products are present in approximately 100 countries worldwide, through a comprehensive network of partners and distributors, among which are major players in the pharmaceutical market segments in which Fidia Pharma Group operates, as well wholly-owned subsidiaries in strategic markets.

A driver for competitiveness is the acknowledged leadership in the development and marketing of unique HA-based products. Fidia operates in diverse therapeutic areas, providing a wide array of treatment options - medicinal products, medical devices, and nutritional supplements – selecting new molecules and/or developing innovative technologies for hyaluronic acid.
Photo Company 3
 

- Over 100 markets worldwide
- Nearly 70% of total sales are generated in foreign markets
- More than 1,200 employees globally

Fidia
Farmaceutici S.p.A.
Website

Find out our Corporate Website:

Go to the website

Fidia’s other websites

Direct link to:

Key Business Areas

Drawing on the strengths of the parent company, Fidia Pharma Middle East product portfolio focalizes primarily on therapeutic areas such as joint healthcare and tissue repair.

Fidia Pharma Middle East is focused on providing consumers with innovative products that offer quality, safety and performance and exploring innovative channel strategies to access customers and consumers, such as healthcare e-commerce.